Clinical Trial Update: CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation [Phase 2]

View source ↗

Summary

Phase 2 trial of dapagliflozin in patients with failing Fontan circulation is currently recruiting. The study also considers effects in single-ventricle heart d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fontan Circulation
• Heart Failure with Preserved Ejection Fraction
• Single-ventricle Heart Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mayo Clinic | Conditions: Fontan Circulation, Single Ventricle Heart Disease | Phase 2 | Status: RECRUITING